willdate

797 POSTS 0 COMMENTS

Cardiovascular News’ top 10 most popular news stories of June 2022

The most read stories from across Cardiovascular News in June 2022 include highlights from TVT 2022 ...

Female representation in interventional cardiology remains low, but there is cause for hope

Suzanne Baron and Ki Park detail some of the barriers facing women in the field of interventiona...

Advanced NanoTherapies closes Series A funding round

Advanced NanoTherapies has closed a US$7.2 million Series A equity financing round marking a tot...

EuroPCR 2022 hears positive results for Trilogy TAVI system in AS and AR patients

Results from the first commercial implants of the Trilogy transcatheter aortic valve implantatio...

First patients enrolled in Manta Ultra vascular closure device study

Teleflex has announced the first patient enrolment in a clinical study that is intended to demon...

AF after surgery is linked to an increased risk of heart failure hospitalisation

People who develop an arrhythmia after surgery have an increased risk of subsequently being admitted...

Acutus launches expanded suite of left-heart access products

Acutus Medical has announced the commercial launch of an expanded suite of left-heart access pro...

CABG “associated with favourable outcomes and increased long-term survival” among octogenarians

A retrospective study from Kubkin Choi and researchers from Mayo Clinic (Rochester, USA) has found t...

CONFORM pivotal trial of CLAAS system begins enrolment

Conformal Medical has announced the launch of the CONFORM pivotal trial with the enrolment of th...

TVT 2022: DAPT after Watchman FLX LAAO is comparable to currently approved regimens

Dual antiplatelet therapy (DAPT) after left atrial appendage occlusion (LAAO) using the Watchman...

TVT 2022: Late-breaking data point to favourable haemodynamic performance of latest-generation TAVI device

Transcatheter aortic valve implantation (TAVI) with the Acurate neo2 (Boston Scientific) device ...

TVT 2022: EXPAND registry shows benefit of MitraClip in patients outside of COAPT trial criteria

Analysis of the EXPAND registry, looking at one-year outcomes of MitraClip treatment in secondar...

TVT 2022: New data “debunk idea that patients with pacemakers may not be eligible for TEER”

Data from the first report on patients with a pacemaker lead across the tricuspid valve have sho...

First patient treated in HEAL-IST clinical trial

AtriCure has announced that the first patient has been treated in the HEAL-IST trial, evaluating the...

Patients with mitral annulus calcification at higher risk of mitral valve dysfunction

A retrospective review of more than 24,000 patients who underwent an electrocardiogram (ECG) has fou...

First-in-human results of Captis embolic protection device presented at EuroPCR 2022

Filterlex Medical has announced results from a first-in-human (FIH) study demonstrating the safe...

Meta-analysis reveals “global collateral damage” of pandemic on cardiovascular care

A study has revealed the “global collateral damage” caused by the disruption to cardiac services cau...

UK-wide randomised trial reports non-inferiority of TAVI to SAVR for all-cause mortality at one year

Transcatheter aortic valve implantation (TAVI) was found to be non-inferior to surgery for all-c...

EuroPCR 2022: DISCO RADIAL finds comparable radial artery occlusion rate between two access strategies

The use of distal radial artery access for percutaneous coronary intervention (PCI) comes at the...

AATS 2022: Concurrent tricuspid valve surgery and LVAD implantation do not lower the incidence of right heart failure

Concurrent tricuspid valve surgery and left ventricular assist device (LVAD)  implantation did n...

SCAI 2022: Analysis looks at coronary IVL outcomes in women and men

New data confirming one-year outcomes with coronary intravascular lithotripsy (IVL, Shockwave Me...

SCAI names Sunil Rao as incoming president

Sunil Rao (Duke University Health System, Durham, USA) has assumed the office of president of th...

Cordella meets safety and efficacy endpoints in SIRONA 2 clinical trial

Endotronix has announced data from the SIRONA 2 clinical trial evaluating safety and efficacy of...

EuroPCR 2022: Sustained reduction in TR seen at one-year in CLASP TR study

One-year outcomes of the CLASP TR study, investigating the use of the Pascal (Edwards Lifesciences) ...

EuroPCR 2022: Single-digit pacemaker rates seen in TAVI with cusp overlap technique

Use of the cusp overlap technique for the deployment of devices in transcatheter aortic valve im...

EuroPCR 2022: First-in-human results of SavvyWire TAVI guidewire support safety

Results of the 20-patient, first-in-human clinical study supporting the safety and efficacy of the S...

EuroPCR 2022: Impact of COVID-19 lockdown on STEMI care revealed

Patients in England with ST-elevation myocardial infarction (STEMI) had an average loss of 1.86 ...

SCAI 2022: PCI for STEMI “yet to reach pre-pandemic levels”

Analysis of data from a US-wide health system suggests that the volume of percutaneous coronary inte...

Biotronik shares new safety data for Magmaris scaffold system at EuroPCR 2022

Biotronik has shared new data presented at EuroPCR 2022 (17–20 May, Paris, France) focused on th...

EuroPCR 2022 hears new data on robotic PCI

New data on robotic-assisted percutaneous coronary intervention (PCI) have been presented during a l...

EuroPCR 2022: Short DAPT shows benefit for high-bleeding risk patients regardless of PCI complexity

Analysis of the MASTER DAPT trial, presented as a late-breaking trial at EuroPCR 2022 (17–20 May, Pa...

EuroPCR 2022: Studies underscore potential of renal denervation as an adjunctive therapy for hypertension

Late-breaking trial data presented at EuroPCR 2022 (17–20 May, Paris, France) underscore the pot...

Medtronic gains FDA approval for Onyx Frontier drug-eluting stent

Medtronic has announced that it has received US Food and Drug Administration (FDA) approval for the ...

Cardiovascular News 65 – May 2022: US Edition

In this issue: New data hint at positive performance of TAVI on structural valve durability ...

Cardiovascular News 65 – May 2022: OUS Edition

In this issue: New data hint at positive performance of TAVI on structural valve durability ...

Analysis charts “significant” growth of US TEER procedures since 2012

A US analysis comparing trends in transcatheter and surgical mitral valve repair (SMVR) has found a ...

Abbott funds programme to boost diversity in clinical trial leadership

Abbott has announced a new partnership with Women as One to launch a new programme designed to train...

Vijay Kunadian

Vijay Kunadian (Newcastle University and Newcastle upon Tyne Hospital NHS Foundation Trust, Newcastl...

ADVERTORIAL: Cath lab technologies for medicine in the precision age

This advertorial is sponsored by Siemens Healthineers In the modern cath lab, having a suite of t...

ADVERTORIAL: TAVI valve durability under the microscope

This advertorial is sponsored by Medtronic Due to the growth of transcatheter aortic valve im...

Cardiovascular News’ top 10 most popular stories of April 2022

The most read stories from across Cardiovascular News in April 2022 include highlights and late-brea...

DCB in PCI: Adjunctive therapy or standard of care?

This educational supplement, sponsored by Medtronic, explores the science underpinning the use of dr...

“TAVI was my baby, now it is a teenager”

In the history of transcatheter aortic valve implantation (TAVI), 16 April 2002 is a landmark date, ...

Health Canada approval granted for SavvyWire TAVI guidewire

OpSens has announced that it has received Health Canada approval for the SavvyWire, its new guidewir...

Japanese and US regulatory approvals granted for BioFreedom stent

Biosensors International Group has announced both the Japanese Pharmaceuticals and Medical Devic...

First patient enrolled in EXPAND TAVR II trial

Medtronic has announced the first patient enrolment in the EXPAND TAVR II pivotal trial, the fir...

SCAI issues position paper on transaxillary arterial access

The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official posit...

Translumina announces launch of dual drug polymer-free coated stent

Translumina has announced the launch of Vivo Isar, its latest generation dual drug polymer-free coat...

“Hybrid” model likely to be a hallmark of the post-pandemic era for heart failure care

The pandemic saw a boom in the use of remote technologies and telehealth for patient monitoring ...

FDA approves coronary use of XO Cross support catheter system

Transit Scientific has announced US Food and Drug Administration (FDA) clearance of its XO Cross...

Quest International and CathWorks partner to scale up FFRangio

Quest International and CathWorks have announced a strategic partnership. Quest has been selecte...

VenusP-Valve gains CE mark

Venus Medtech's transcatheter pulmonic valve replacement (TPVR) system—VenusP-Valve—has received...

CeloNova to seek medical device partnerships

CeloNova BioSciences has announced the strategic decision to focus its core business on creating...

ACC.22: TAVI patients treated with edoxaban see fewer incidences of leaflet thrombosis compared to DAPT

Patients treated with edoxaban for six months after a transcatheter aortic valve implantation (T...

Cardiovascular News’ top 10 most popular stories of March 2022

The most read stories from across Cardiovascular News in March 2022 include a wealth of late-breakin...

FEops Heartguide receives FDA clearance for LAAO planning capabilities

FEops has announced that it received authorisation from the US Food and Drug Administration (FDA...

First patient in Japan treated with Impella 5.5 with SmartAssist

Abiomed has announced that the first patient in Japan has been treated successfully with Impella...

First patient enrolled in BIOMICS study for CTO-PCI

Biosensors International has announced the enrolment of the first patient in the BIOMICS study, a pr...

ACC.22: Analysis finds lower rate of structural valve deterioration with TAVI than SAVR at five years

Patients who received a transcatheter supra-annular self-expanding heart valve had less structural d...

ACC.22: NACMI registry finds reducing rates of death among STEMI patients with COVID-19

Latest results from the North American COVID-19 STEMI (NACMI) registry reported a 25% reduction ...

ACC.22: FFR-guided PCI non-inferior to IVUS for intermediate coronary stenosis

A head-to-head comparison of fractional flow reserve (FFR) and intravascular ultrasound (IVUS) guide...

ACC.22: Three-year data show “durable blood pressure reductions” through renal denervation

Long-term data from the first 80 patients in the SPYRAL HTN-ON MED trial have been presented during ...

ACC.22: “Promising” one-year results for Pascal device in CLASP-TR trial

Patients with tricuspid regurgitation (TR) who received a Pascal transcatheter valve (Edwards Lifesc...

Corvia announces publication of REDUCE LAP-HF II data

Corvia Medical has announced publication of analyses from its global, phase III REDUCE LAP-HF II...

ACC.22: FAME 3 shows FFR-guided PCI leads to a faster recovery versus surgery

Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) leads to a fast...

SafeCross transseptal balloon gets first commercial use

East End Medical has announced the first commercial use of its SafeCross transseptal radiofreque...

Philips launches Ultrasound Workspace at ACC.22

Royal Philips is launching an echocardiography image analysis and reporting solution—Ultrasound Work...

SCAI aims to minimise risks in medical proctoring of new techniques and technologies

The Society for Cardiovascular Angiography & Interventions (SCAI) has released an official posit...

FDA approval granted for Mitris Resilia mitral valve replacement

Edwards Lifesciences has announced it received approval from the US Food and Drug Administration (FD...

Shockwave coronary IVL gains Japanese approval

Shockwave Medical’s C2 coronary intravascular lithotripsy (IVL) catheter has received regulatory app...

First patient enrolled in PICSO-AMI-V study

Miracor Medical has announced the first patient enrolled in the PICSO-AMI-V study to evaluate Pi...

RADIANCE-II renal denervation trial completes enrolment

Investigators have completed enrolment in the RADIANCE-II pivotal trial of the Paradise ultrasound r...

Carmat sets date for resumption of implants of artificial heart system

Carmat, designer and developer of an advanced total artificial heart, has issued an update on it...

Deep learning tool could predict future myocardial infarction

Researchers have detailed the use of an artificial intelligence-enabled tool for atherosclerotic...

First-in-human study paves way for further clinical trials of Valvosoft

Cardiawave has announced the success of its first-in-human I (FIH I) safety and feasibility clinical...

Expert group sets out principles for device-led hypertension trials

A consensus document outlining design principles and outcome definitions for device-based therapies ...

Medical Ingenuities conducts first commercial cases with transformational radial haemostasis band system

Four radial cases using the PH Band System (Medical Ingenuities)—a novel medical device that is ...

Venus Medtech targets European growth with senior appointment

Venus Medtech has appointed Shakeel Osman as senior vice president of sales Europe, responsible for ...

Women less likely to receive cardiogenic shock treatment

Woman patient
Women are less likely to receive lifesaving treatment for cardiogenic shock than men, according to r...

Dyspnoea and fatigue “warning signs of greater risk” for NSTEMI patients

Only 76% of heart attack patients with dyspnoea or fatigue as their main symptom are alive at one ye...

Putting “stent regret” behind us

Nick West, chief medical officer and divisional vice president of Global Medical Affairs, Abbott...

Xeltis announces “promising outcomes” in restorative graft trials following EU financing

Xeltis has announced promising initial outcomes from two key vascular trials involving its restorati...

ACC issues clinical guidance on cardiovascular consequences of COVID-19

The American College of Cardiology (ACC) has issued an expert consensus decision pathway for the eva...

CSI’s Propel pVAD system gets first-in-human use

Cardiovascular Systems—CSI—has announced the first in-human experience with Propel, its first-genera...

First patient treated in study of PerQseal+ vessel closure device

Vivasure Medical has announced today that the first patient was treated in a US early feasibilit...

Cardiologists without borders

“When I was one year old, my father died in the war between Israel and Egypt and I was left with...

Ryan Egeland joins Big Sky Biomedical

Big Sky Biomedical has appointed Ryan Egeland as managing director. “Big Sky Biomedical was f...

Medtronic expands reach of AI-powered surgical video management and analytics platform

Medtronic has announced that it has entered into a contract with Vizient to add Touch Surgery En...

Cardiovascular News’ top 10 most popular stories of February 2022

The most read stories from across Cardiovascular News in February 2022 include training for robotic ...

CRT 2022: “Reassuring” two-year outcomes for bicuspid TAVI

Two-year findings from the Low-risk TAVI (LRT) Trial, assessing clinical outcomes after transcat...

CRT 2022: Novel transfemoral mitral valve repair technology wins innovation competition

A novel transcatheter system designed for transfemoral mitral valve repair—the NeoChord Nexus sy...

CRT 2022: COBRA-REDUCE findings do not support routine use of nanocoated stent with short-duration DAPT

Final findings from the COBRA-REDUCE randomised trial assessing 14-day dual antiplatelet therapy...

CRT 2022: Four-year LRT data “support TAVI in low-risk patients”

Four-year data from the LRT—Low Risk TAVR—trial show that transcatheter aortic valve implantatio...

VISION study concludes troponin is a benchmark for cardiac surgery risk

Levels of high-sensitivity troponin I after cardiac surgery that were associated with an increased r...

Enrolment in BIOMAG-I trial of resorbable magnesium scaffold completed

Biotronik has announced final enrolment in the BIOMAG-I clinical trial by Michael Haude (Rheinla...

CRT 2022: SURPASS registry shows low rate of adverse events associated with Watchman FLX

Results from a new analysis assessing real-world outcomes with the Watchman FLX (Boston Scientif...

Women underrepresented in cardiovascular clinical trial leadership positions

Women remain underrepresented in leading cardiovascular clinical trials, corresponding with unde...

CRT 2022 hears results of animal study of Tria TAVI valve

Tria
Results from the first animal study of the Tria transcatheter aortic valve (Foldax) have been pr...

CRT 2022: Final BIOFLOW-V results “affirm durability” of Orsiro out to five years

Final five-year results from the BIOFLOW-V trial, presented during a late-breaking trial session...

Partnership to promote wearable tech in cardiology trials

Wearable technology and digital health specialist Activinsights has announced a partnership agreemen...

High coronary artery calcium score increases risk of heart attack or stroke

Patients with both a high lipoprotein(a) and high coronary artery calcium score (CAC) face a mor...

CX 2022 returns to in-person format facing challenges and opportunities in the aortic field

Anticipation is building for the Charing Cross International Symposium 2022 (CX 2022). This will...

Teleflex catheters and coronary guidewires cleared for CTO PCI

Teleflex has announced that the US Food and Drug Administration (FDA) has cleared an expanded indica...

New data underpin drive towards earlier AF ablation strategies

Historically, catheter ablation has been reserved for atrial fibrillation (AF) patients who have...

Valve-in-valve TAVI outperforms repeat SAVR for in-hospital mortality

Valve-in-valve transcatheter aortic valve implantation (TAVI) was associated with lower in-hospi...

Siemens introduces “integrated” cath lab imaging system, Artis icono biplane

Siemens Healthineers has announced the launch of Artis icono biplane—an angiography system with dete...

Ross procedure “associated with better long-term outcomes” for aortic valve replacement

The “Ross procedure” may be a more favourable option for aortic valve replacement among patients...

Abbott’s CardioMEMS HF system receives FDA approval for use in earlier-stage heart failure

Abbott has announced that the US Food and Drug Administration (FDA) has approved an expanded indicat...

On-pump and off-pump CABG confer similar outcomes over 10 years

A 10-year study monitoring patients receiving “on-pump” or “off-pump” coronary artery bypass graftin...

Heart team approach points to mortality benefit in complex cardiac patients

Consultation by a heart team led to an observed benefit in objective patient outcomes, a prospective...

New technique outperforms manual assessment of thoracic aortic aneurysm growth

Researchers have developed a novel method of measuring growth of thoracic aortic aneurysm, which the...

Robert Califf to return as US FDA commissioner

Cardiologist and researcher Robert Califf has been confirmed as the commissioner of the US Food ...

Expanded robotic training will benefit cardiovascular care

Robotic systems have the potential to fundamentally change the way care is delivered to patients in ...

3D printing to support physician training and coronary device testing

The donation of new 3D printing technology to the Visible Heart Laboratories at the University o...

Enrolment completed in BIOADAPTOR trial of Dynamx coronary implant

Elixir Medical has announced completion of enrolment in the BIOADAPTOR randomised controlled tri...

Boston Scientific closes acquisition of Baylis Medical Company

Boston Scientific has announced the close of its acquisition of Baylis Medical Company, a compan...

MedHub announces investment and pivotal study completion

MedHub has announced the completion of a funding round worth US$1 million in new financing, alongsid...

Supreme drug-eluting stent “safe and effective” in complex coronary lesions

The Supreme healing-targeted drug-eluting stent (Sinomed) is effective and safe at one year acro...

Portsmouth Hospital: How tech is guiding decision-making in the cath lab

Peter Haworth (Portsmouth Hospitals University NHS Trust, Portsmouth, UK) documents how computer-der...

HeartFlow and Longview terminate merger agreement

HeartFlow has announced that it and Longview Acquisition Corporation have mutually agreed to termina...

Lung cancer patients with higher level of coronary calcium at increased risk for adverse cardiovascular events

Lung cancer patients with higher amounts of coronary artery calcium have an increased risk of an adv...

IVUS “improves long-term cardiac survival” after long drug-eluting stent implantation

The use of intravascular ultrasound (IVUS) guidance for implantation of drug-eluting stents in long ...

Cardiovascular News’ top 10 most popular stories of January 2022

The most read stories from across Cardiovascular News in January 2022 include controversy surroundin...

Acarix submits breakthrough designation request to FDA for heart failure diagnosis tool

Acarix has submitted a breakthrough designation request for its technology for heart failure diagnos...

“Game changing” photon-counting CT system arrives at John Radcliffe Hospital

The John Radcliffe Hospital—part of Oxford University Hospitals NHS Foundation Trust (OUH, Oxfor...

Philips expands haemodynamic assessment in its Lumify handheld ultrasound system

Royal Philips has announced an update to its handheld ultrasound platform—Lumify—adding Pulse Wave D...

Second phase of ASCENT ASD trial begins

Atheart Medical has announced that it has received US Food and Drug Administration (FDA) approva...

Corvia atrial shunt fails to reduce heart failure events in REDUCE LAP-HF II trial

The placement of an interarterial shunt device—the Corvia atrial shunt (Corvia Medical)—did not ...

First patient enrolled in RISE SC study of coronary balloon

Biosensors has announced the enrolment of the first patient in the RISE SC study, a single arm, pros...

Breakthrough designation granted to CardiaAMP cell therapy system for heart failure treatment

BioCardia has announced that the US Food and Drug Administration (FDA) has granted Breakthrough Devi...

CroíValve completes funding round for study of Duo system

CroíValve has raised a Series A round to fund a feasibility clinical study with its Duo Coaptati...

SCAI publishes expert consensus statement on sex-specific considerations in myocardial revascularisation

The Society for Cardiovascular Angiography & Interventions (SCAI) has announced the release ...

Abbott’s Nick West points to future role of AI in the cath lab

Abbott has released a second round of insights from its Beyond Intervention global research prog...

ADVERTORIAL: Fresh data paint a positive picture for IVL in both eccentric and nodular coronary calcium

This advertorial is sponsored by Shockwave Medical. The latest data from the Disrupt CAD clinical...

ADVERTORIAL: Evolut PRO+ provides options in the toughest TAVI cases

This advertorial is sponsored by Medtronic. Evolut PRO+ is the latest generation of self-expandin...

Susheel Kodali

Born in India and raised in Pittsburgh, USA, Susheel Kodali now practices in New York, where he ...

Cardiovascular News 64 – February 2022: US Edition

In this issue:  Coronary revascularisation guidelines spark debate New data on IVL in eccent...

Cardiovascular News 64 – February 2022: OUS Edition

In this issue:  Coronary revascularisation guidelines spark debate New data on IVL in eccent...

STS 2022: Large-scale analysis points toward positive outcomes in bicuspid aortic stenosis patients receiving surgery

Insights from what was described as the “largest and most comprehensive” analysis of isolated su...

PROACT clinical trial results published for On-X mechanical mitral valve

Artivion has announced the publication of PROACT clinical trial results in The Annals of Thoracic Su...

SCAI issues updated expert consensus statement on cardiogenic shock

The Society for Cardiovascular Angiography and Interventions (SCAI) has released its updated exp...

STS 2022: Closer ties between surgeons and cardiologists among goals for incoming president

Cardiothoracic surgeon John H Calhoon from The University of Texas Health Science Center (UT Hea...

STS 2022: Socioeconomic status may impact outcomes after mitral valve surgery

Patients with mitral valve disease who live in disadvantaged communities are more likely to expe...

InnovHeart completes funding round to advance Saturn TMVR system

InnovHeart, developer of novel transcatheter mitral valve replacement (TMVR) systems for the treatme...

JIM 2022 moves to June slot

Organisers of the Joint Interventional Meeting (JIM) have announced that the 2022 edition of the eve...

First patient enrolled in TRANSFORM II study of sirolimus-coated balloon

The first patient has been enrolled in the TRANSFORM II randomised controlled trial assessing th...

“Considerable” reduction in PCI-related radiation reported in last decade

Radiation exposure during percutaneous coronary intervention (PCI) has fallen “considerably” during ...

Burden of aortic stenosis likely to challenge UK treatment capacity, researchers warn

Researchers have warned that the number of people suffering from aortic valve stenosis in the UK cou...

Grant funding for 3D-printed paediatric heart models

Congenita has been named a recipient of the MedTech NAVIGATOR Innovation Grant Scheme, run by NHS me...

Guidelines recognise potential role for earlier endovascular treatment of uncomplicated type B aortic dissection

New clinical practice guidelines have been published today, and are intended to act as “guard rails”...

Scoreflex NC PTCA catheter gains FDA premarket approval

Cardiovascular Systems (CSI) and OrbusNeich Medical Company have announced US Food and Drug Administ...

Gore’s Cardioform Septal Occluder reaches 10-year milestone

WL Gore & Associates has announced that its Cardioform Septal Occluder has achieved 10 years...

Young surgeons to benefit from Transatlantic grant scheme

In a joint programme between the Society of Thoracic Surgeons (STS) and the European Association...

TAVI associated with reduced odds of in-hospital mortality for bicuspid valve patients

A propensity score-matched analysis of the early outcomes of transcatheter aortic valve implantation...

Pioneering pig to human heart transplant heralded as a breakthrough

A 57-year-old patient with terminal heart disease received a successful transplant of a genetically-...

AATS and STS opt not to endorse joint coronary revascularisation guidelines

The American Association for Thoracic Surgery (AATS) and The Society of Thoracic Surgeons (STS) have...

Omicron surge sees STS move 2022 annual meeting online

The Society of Thoracic Surgeons (STS) has moved its 2022 annual meeting from an in-person to a virt...

Terumo welcomes upgraded recommendation for radial access in revascularisation guidelines

Terumo Medical Corporation has welcomed the publication of updated guidelines from the American Coll...

Robocath completes European study of robot-assisted PCI

Robocath has announced the conclusion of its R-Evolution clinical study in Europe, which was aimed a...

Impella gains a trio of regulatory approvals

Regulators in three countries have granted approvals to Impella surgical products. In the USA, the F...

Evolut PRO TAVI valve gains approval in China

Medtronic has announced that the National Medical Products Administration (NMPA) has approved th...

Cardiovascular News’ top 10 most popular stories of December 2021

The most read stories from December 2021 include analysis of the CHEETAH study and the role of mecha...

First patient enrolled in COSIRA-II trial of Neovasc Reducer

Neovasc has announced enrolment of the first patient in the COSIRA-II clinical trial. COSIRA-II (...

Endotronix announces FDA approval for PROACTIVE-HF pivotal trial design change

Endotronix has announced that the US Food and Drug Administration (FDA) has granted approval for...

Partnership to develop training system for complex valve-in-valve procedures

Biomodex and the Montreal Heart Institute (MHI, Montreal, Canada) are partnering to develop a ne...

FDA clears CavaClear IVC filter removal laser sheath

Royal Philips has announced US Food and Drug Administration (FDA) de novo clearance for the Phil...

First clinical results for Tria biopolymer valve published

Tria
Foldax has announced publication of the first clinical results for its Tria biopolymer heart val...

Sapien 3 with Alterra prestent gains FDA approval

Sapien 3
Edwards Lifesciences has received approval from the US Food and Drug Administration (FDA) for th...

Research suggests many patients may be safely discharged without opioids after cardiac surgery

Many patients undergoing cardiac surgery may be able to safely and effectively control postoperative...

EMPAKT CHF trial points to change in assessment acute heart failure patients

FAST BioMedical has announced the publication of additional results from the EMPAKT CHF (Estimating ...

Initial implants of Thubrikar TAVI system to commence

Thubrikar Aortic Valve has received approval from a Competent Authority in Poland to conduct initial...

AI improves confidence in CAD detection from a stress echocardiogram

Ultromics has announced the publication of a study assessing its EchoGo platform, powered by Art...

HeartFlow submits premarket application for coronary plaque assessment

HeartFlow has announced it has submitted a 510(k) premarket application to the US Food and Drug Admi...

“Tantalising” data open the door for further study of mechanical aspiration thrombectomy with PCI

Results of the CHEETAH clinical study highlight the potential role of mechanical aspiration thro...

Svelte Medical Systems receives US FDA approval for Slender IDS and Direct RX

Svelte Medical Systems has received US Food and Drug Administration (FDA) approval to commercialise ...

Opsens files 510(k) submission to US FDA for TAVI guidewire

Opsens has filed a 510(k) submission with the US Food & Drug Administration (FDA) for regulatory...

Joanna Chikwe appointed as editor-in-chief of The Annals of Thoracic Surgery

The Society of Thoracic Surgeons (STS) has appointed Joanna Chikwe (chair of the Department of Cardi...

Understanding the risk of acute kidney injury in the cath lab

Huge strides have been made in preventing contrast-associated acute kidney injury among patients...

Heart team approach central to updated coronary revascularisation guidelines

New guidelines for coronary artery revascularisation recommend that treatment decisions should be ba...

Coronary artery modelling technology enables 3D reconstruction of coronary vasculature

RSIP Vision has announced a new coronary artery modelling technology, which enables reconstruction o...

Philips expands cardiac ultrasound portfolio

Royal Philips has announced an expansion of its ultrasound portfolio with new imaging tools and ...

Foldax commences clinical study of Tria surgical aortic valve in India

Tria
Foldax has announced that the Drugs Controller General of India (DCGI), India’s regulatory body for ...

Venus Medtech announces Cardiovalve acquisition

Venus Medtech has announced its acquisition of Cardiovalve, a transcatheter mitral and tricuspid val...

SyMap Medical closes US$100 million financing round

SyMap Medical has announced the completion of a financing round which will be used to accelerate...

Restore Medical announces preliminary results from first-in-human use of ContraBand

Restore Medical has announced preliminary results of the first-in-human clinical trial of ContraBand...

Survey: Bullying “commonly experienced” by UK cardiology trainees

One in 10 junior doctors training to be cardiologists in the UK say they have been bullied, the resu...

Interim REVERSE-IT trial results published in NEJM Evidence

Interim results from the REVERSE-IT trial of bentracimab (PhaseBio Pharmaceuticals), which is de...

Cardiovascular News’ top 10 most popular stories of November 2021

Featuring stories from the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021, 4–6 N...

AI-based algorithm could predict outcomes after cardiac surgery

AI
A novel artificial intelligence (AI) algorithm that identifies a cardiac dysfunction from a single-l...

Soundbite Medical gains fifth US patent for its plaque modification technology

Soundbite Medical Solutions has announced that the US Patent and Trademark Office has issued a paten...

Robocath announces completion of first robotic coronary angioplasty with R-One in China

Robocath has announced the successful completion of what it has described as the first coronary angi...

TMVI is a “reproducible and reliable” tool for eliminating mitral regurgitation

Findings of the CHOICE MI registry show that transcatheter mitral valve implantation (TMVI) is a...

PCR London Valves 2021: ENVISAGE TAVI AF and the future of TAVI trials

TAVI
Findings from an on-treatment major bleeding analysis from the ENVISAGE TAVI AF trial, presented...

Mirvat Alasnag

Mirvat Alasnag is the Gulf region’s first female interventional cardiologist. Currently the director...

CSI recalls Wirion embolic protection device

Cardiovascular Systems has initiated a voluntary recall of unused Wirion embolic protection systems ...

PCR London Valves: Two-year GALILEO data show comparable outcomes for TAVI with self-expanding or balloon-expandable valves according to physician discretion

Two-year findings of a post-hoc study from the GALILEO trial, investigating the clinical outcome...

PCR London Valves: First clinical data backs use of Jenavalve TAVI system in patients with aortic regurgitation

First clinical results of transcatheter aortic valve implantation (TAVI) using the Jenavalve sys...

PCR London Valves hears first results from NeoChord Nexus mitral repair device

The first 30-day results following the implantation of the NeoChord NeXuS transcatheter system f...

First 20 patients treated in first-in-man study of SavvyWire TAVI guidewire

Opsens has announced the successful treatment of 20 patients leading to the completion of the first ...

First patients enrolled in FAST III study of vFFR-guided PCI

The first patients have been enrolled in the FAST III trial at the Erasmus University Medical Center...

ESC publishes pandemic guidance on diagnosis and management of cardiovascular disease

European Society of Cardiology (ESC) guidance for the diagnosis and management of cardiovascular dis...

SCAI pushes revised standardised language to improve cardiogenic shock care

New guidance on the diagnosis and presentation of cardiogenic shock aims to simplify and standar...

Findings of meta-analysis “move the conversation forward” on left main revascularisation

A meta-analysis comparing percutaneous coronary intervention (PCI) using a drug-eluting stent (D...

AHA 2021: Updated risk score aims to predict contrast-associated kidney injury after PCI

An updated risk score to predict possible contrast-associated acute kidney injury (CA-AKI) among...

AHA 2021: VEST device may lead to increased saphenous vein graft longevity after CABG

Use of a novel, venous external support device (VEST, Vascular Graft Solutions) may lead to incr...

HeartVista receives FDA clearance for use of its AI software on Siemens MRI scanners

HeartVista has received US Food and Drug Administration (FDA) 510(k) clearance to deliver its AI-ass...

AHA 2021: RAPID CABG trial finds in favour of bypass surgery sooner after ticagrelor cessation

Coronary artery bypass graft sugery (CABG) between two and three days after ticagrelor cessation was...

AHA 2021: Asymptomatic AS patients benefit from early valve replacement surgery

Asymptomatic patients with severe aortic stenosis (AS) may benefit from early aortic valve replaceme...

What to expect from AHA 2021

Ahead of the American Heart Association’s 2021 annual scientific sessions (AHA 2021, 13–15 November,...

ADVERTORIAL Chronic total occlusion: The last frontier in the cath lab

This advertorial is sponsored by iVascular Treatment of a chronic total occlusion (CTO)—a complet...

“Promising” early data shared on alternatives to paclitaxel DCBs at TCT 2021

Early data presented at the Transcatheter Cardiovascular Therapeutics annual meeting (TCT 2021; ...

Abbott research highlights opportunities for improvements in diagnosis and treatment of cardiovascular disease

Abbott has released new research from its Beyond Intervention initiative, a multi-year global resear...

Ron Waksman joins SIS Medical AG advisory board

SIS Medical AG has appointed Ron Waksman, associate director Division of Cardiology, MedStar Was...

Lessons from SURTAVI

Transcatheter aortic valve implantation (TAVI) pioneer and principal investigator of the SURTAVI tri...

Cardiovascular Systems announces enrolment in first-in-human study of everolimus-coated coronary DCB

Cardiovascular Systems has announced the start of enrolment in a first in-human trial of the coronar...

Patients more likely to survive a cardiac arrest in the operating room than the cath lab

Patients who went into cardiac arrest in the cardiac cath lab were more likely to survive to hospita...

Two-year results of mitral valve repair using ChordArt device published

CoreMedic has announced the publication of two-year follow-up results from the first in-human CHAGAL...

Medtronic announces 2045 net zero emissions ambition to combat climate change

Medtronic has announced its ambition to achieve net zero carbon emissions by fiscal year 2045 across...

TCT 2021: BIOSOLVE-IV data offer reassurance over rates of scaffold thrombosis from Magmaris bioresorbable scaffold

Data from the BIOSOLVE-IV trial, presented at the Transcatheter Cardiovascular Therapeutics annu...

TCT 2021: Six-month TRISCEND results “encouraging” for Evoque tricuspid valve

Six-month results from the TRISCEND study of the Evoque (Edwards Lifesciences) transcatheter tri...

TCT 2021: Early data presented for Intrepid TMVR using transfemoral delivery system

Early data for the self-expanding Intrepid (Medtronic) transcatheter mitral valve replacement (T...

TCT 2021: SWISS-APERO trial finds lower rate of peri-device leak in Amulet compared to Watchman FLX LAAC device

Findings of the SWISS-APERO trial, presented at the Transcatheter Cardiovascular Therapeutics an...

TCT 2021: Endoscopy study could have implications for post-PCI antiplatelet regimens

Patients receiving antiplatelet therapy following percutaneous coronary intervention (PCI) devel...

TCT 2021: Studies show improved outcomes for high-risk PCI patients using Impella

The final results of the PROTECT III and Restore EF prospective studies demonstrate improved out...

TCT 2021: LAAC remains non-inferior to NOAC for cardiovascular events at long-term follow-up

Left atrial appendage occlusion (LAAC) remains non-inferior to non vitamin-K-antagonists (NOACs)...

TCT 2021: Five-year SURTAVI data show comparable performance for TAVI and SAVR on mortality, stroke

Five-year clinical and echocardiographic outcome data from the SURTAVI randomised trial comparin...

TCT 2021: CHOICE-CLOSURE finds higher rate of access-related vascular complications in plug-based closure strategy post-TAVI

Results from the largest randomised trial to date comparing different closure device strategies ...

TCT 2021: TAVI in low-risk patients is cost effective, PARTNER 3 finds

An economic analysis of data from the PARTNER 3 randomised trial, comparing transcatheter aortic...

TCT 2021: CHEETAH study demonstrates safety of continuous aspiration to remove blood clots in the heart

Penumbra has announced that the CHEETAH clinical study of its Indigo system CAT RX catheter succ...

TCT 2021: “Sustained benefit” in patients undergoing IVL prior to coronary stenting

One-year outcomes from the Disrupt CAD III clinical study of Shockwave intravascular lithotripsy (IV...

TCT 2021: Patients with diabetes undergoing PCI have less target lesion failure with amphilimus-eluting stents

Results from SUGAR, a randomised controlled, multicentre trial conducted exclusively in patients wit...

TCT 2021: Randomised trials show “consistent” reduction in blood pressure through renal denervation

Randomised placebo-controlled trials show consistently that renal denervation provides significant r...

TCT 2021: Six-month RADIANCE-HTN TRIO results “open a window” for renal denervation

Six-month outcomes from the randomised RADIANCE-HTN TRIO trial, comparing endovascular ultrasoun...

TCT 2021: QFR-guided lesion selection improves PCI outcomes in FAVOR III trial

Lesion selection for percutaneous coronary intervention (PCI) using the non-invasively assessed phys...

TCT 2021: CABG “remains the treatment of choice” for complex, three-vessel coronary artery disease

Percutaneous coronary intervention (PCI) guided by fractional flow reserve (FFR) did not meet no...

Cardiovascular News 63 – November 2021: US Edition

In this issue:  MASTER DAPT game changing for short-duration dual antiplatelet therapy (DAPT) ...

Cardiovascular News 63 – November 2021: OUS Edition

In this issue:  MASTER DAPT game changing for short-duration dual antiplatelet therapy (DAPT) ...

TCT 2021: Philips to showcase developments in its interventional portfolio

Royal Philips has previewed updates in its product portfolio and new data due to be shared at the Tr...

Procyrion’s Aortix percutaneous mechanical circulatory support device features at TCT 2021

Procyrion has announced the presentation of studies at the Transcatheter Cardiovascular Therapeutics...

Aktiia announces Series A funding round

Hypertension health-tech firm Aktiia has announced a US$17.5 million Series A round of funding t...

ReValve Solutions announces first use of its Palmetto mitral valve replacement system

ReValve Solutions has announced that it has successfully completed the first-in-human use of its tra...

TCT 2021: Studies to highlight patient outcomes with Impella

Results from two studies of the Impella heart pump device will be presented at the Transcatheter Car...

Bifurcation lesions: Exploring the latest science

This educational supplement, sponsored by Medtronic, explores the latest evidence covering the treat...

AHA and ACC release clinical guidelines for evaluation of chest pain

Joint clinical practice guidelines have been issued by the American Heart Association (AHA) and the ...

EACTS speakers question evidence underpinning guidelines for left main revascularisation

Speakers at the European Society of Cardio-Thoracic Surgery annual meeting (EACTS 2021; 13–16 Octobe...

Longest available real-world follow-up data for Tendyne valve support use of device in select patients

The longest available real-world follow-up data of transcatheter mitral valve implantation (...

Enrolment completed in study of Teleflex QuikClot device

Teleflex announced the completion of patient enrolment in a clinical study evaluating the performanc...

Research finds poor level of surveillance following aortic dissection repair

Patients who survive an aortic dissection often fail to receive ​​comprehensive post-surgical fo...

CRF waives cost for digital access to TCT 2021

The Cardiovascular Research Foundation (CRF) has announced that the digital component of the Transca...

PIONEER III trial results demonstrate safety and efficacy of HT Supreme stent

Sinomed has announced that the PIONEER III clinical trial results for its HT Supreme drug-elutin...

Cardiac CTA parameters predict post-TAVI mortality

Cardiac CT angiography (CTA) derived left atrium emptying fraction (LAEF) improves predictive pe...

First European implants of Trilogy TAVI system completed

JenaValve Technology has announced the first commercial implants with the Trilogy heart valve System...

Heartflow announces start of REVEALPLAQUE clinical trial

HeartFlow has announced the commencement of the REVEALPLAQUE trial to evaluate the company’s non-inv...

Study charts “inequities” in growth of TAVI in US hospitals

The expansion of transcatheter aortic valve implantation (TAVI) in the USA has predominantly centred...

Ethnic and racial minority cardiologists face professional discrimination and exclusion

Ethnic and racial minority cardiologists report career satisfaction but face professional discrimina...

EACTS 2021: Panel urges action over lack of representation of women in coronary revascularisation trials

The underrepresentation of women in clinical coronary revascularisation trials may encourage tre...

Clinical study of SavvyWire TAVI guidewire commences

OpSens has announced the commencement of the human clinical study utilising the SavvyWire, and succe...

Next generation of aortic surgeons need open and endovascular skills

Building and maintaining expertise in both open and endovascular surgical techniques will play a...

ReCor Medical’s Paradise ultrasound renal denervation system used in first German cases

ReCor Medical has announced that its Paradise ultrasound renal denervation system is now available f...

Baylis Medical Company to sell its cardiology business to Boston Scientific

Baylis Medical Company has reached an agreement to sell its cardiology business to Boston Scientific...

Philips’ Bert van Meurs discusses the future of imaging in the cath lab

Bert van Meurs is the chief business leader for Image Guided Therapy within Royal Philips, the multi...

NeoChord announces completion of first-in-human case with NeXus TMVr technology

NeoChord has announced successful completion of the first-in-human procedure with the NeoChord NeXuS...

Cardiovascular News’ top 10 most popular stories of September 2021

Top stories for September included more highlights from the European Society of Cardiology’s 2021 co...

Lankenau Heart Institute and Philips announced integrated cardiovascular solutions partnership

Royal Philips and Lankenau Heart Institute part of Main Line Health (Wynnewood, USA) have announced ...

FDA monitoring gender differences in outcomes with LAAO devices

The US Food and Drug Administration (FDA) has informed healthcare providers of recent information ab...

Enrolment completed in study of Tria aortic valve

Tria
Foldax has announced completion of enrolment in the US early feasibility study of the Tria surgical ...

Siemens launches Luminos Impulse fluoroscopy system

Siemens Healthineers has launched the Luminos Impulse fluoroscopy system, including features such as...

Abbott’s Amplatzer Talisman gains FDA approval

Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's Ampla...

Biotronik gains FDA approval for the Orsiro Mission drug-eluting stent

Orsiro Mission DES
Biotronik has announced that it has received US Food and Drug Administration (FDA) approval of i...

Waiting list mortality for coronary procedures exacerbated during pandemic

Patients awaiting coronary artery bypass grafting (CABG) or percutaneous coronary intervention (...

Open Stent Solution closes €2.5 funding round

Open Stent Solution (OSS) has announced the closing of a €2.5 million Seed financing round. The fund...

HRX digital health event moved to September 2022

The Heart Rhythm Society (HRS) has announced that its cardiovascular digital health conference—HRX—h...

Cardiac, vascular and endovascular leaders convene for CX Aortic Vienna

CX Aortic Vienna
Capturing the latest developments in the comprehensive treatment of aortic disease—from the aortic v...

ADVERTORIAL: Optimising TAVI device choice

This advertorial is sponsored by Medtronic As transcatheter aortic valve implantation (TAVI) ...

Neovasc to begin COSIRA-II trial of Reducer for refractory angina

Neovasc has announced that it has received Food and Drug Administration (FDA) approval for the inves...

FDA approves Abbott’s Epic Plus tissue valves for mitral and aortic valve replacement

Abbott has announced that the US Food and Drug Administration (FDA) has approved the company’s Epic ...

Registry data show comparable outcomes for bicuspid and tricuspid TAVI in low-risk patients

Patients at low surgical risk who had undergone transcatheter aortic valve implantation (TAVI) f...

Surgical team completes first implant of Aeson bioprosthetic heart in a female patient

A cardiothoracic surgical team with UofL Health–Jewish Hospital and the University of Louisville...

Ultrasound guidance “should be routine” for transfemoral TAVI access

Ultrasound-guided transfemoral transcatheter aortic valve implantation (TAVI) is associated with...

Randomised trials needed to evaluate safety and efficacy of TMVR

Randomised trials are needed to evaluate the safety and effectiveness of transcatheter mitral va...

Abbott receives FDA approval for Portico with FlexNav TAVI system

Abbott has announced that the US Food and Drug Administration (FDA) has approved the company's P...

OpSens receives Health Canada approval to begin clinical study of TAVI guidewire

OpSens has announced that it has received Health Canada approval to commence the first in-man study ...

Renal denervation: The most advanced and efficacious interventional approach to treat hypertension

Following the release of the European Society of Hypertension’s (ESH’s) updated position paper o...

Long-term preclinical results of Xeltis’ restorative CABG graft presented at ISACB 2021

One-year data from preclinical trials of Xeltis restorative coronary artery bypass graft (XABG) show...

TCT 2021: Late-breaking trials programme announced

The Cardiovascular Research Foundation (CRF) has announced 22 late-breaking trial and science pr...

ESH position paper highlights renal denervation as a third option for hypertension management

European Society of Hypertension (ESH), the leading hypertension (HTN) society in Europe, presented ...

Peijia Medical announces first implant in the clinical trial of its TaurusNXT TAVI system

Peijia Medical has announced the initiation of its multicentre clinical trial for TaurusNXT, the...

Christoph Naber

Christoph Naber (Essen, Germany) talks to Cardiovascular News about his career in interventional car...

New imaging technique has the potential to identify patients at high risk of aortic degeneration

Four-dimensional (4D) flow magnetic resonance imaging (MRI) has the potential to identify patien...

CytoSorbents files IDE for clinical trial of DrugSorb-ATR used during cardiothoracic surgery

CytoSorbents has filed an investigational device exemption (IDE) application to gain US Food and Dru...

STENTiT makes trio of appointment to its medical advisory board

STENTiT, a medical device company bringing a novel class of regenerative endovascular implants f...

No-touch CABG technique “reduces risk of vein graft occlusion” after 12 months

When a modified surgical technique was used to gently remove sections of leg veins used in coronary ...

ABILITY Diabetes Global enrols thousandth patient

Concept Medical has announced the enrolment of the thousandth patient in ABILITY Diabetes Global (Ra...

Digital app speeds up time to STEMI care

“During a heart attack time is myocardium,” says Annapoorna Kini (New York, USA) discussing the ...

Cannabis use in younger adults linked to increased risk of myocardial infarction

Adults younger than 45 years who reported recently using cannabis were two times more likely to have...

Cardiovascular News’ top 10 most popular stories of August 2021

August’s top 10 features a stark warning over representation of women in clinical trials relating to...

HeartFlow announces enrolment of first three patients in FUSION trial

HeartFlow has announced that physicians at Erasmus MC Hospital (Rotterdam, The Netherlands) have...

ESC 2021: STOPDAPT-2 ACS does not support clopidogrel monotherapy one-month after ACS

Findings of the STOPDAPT-2 ACS trial presented during a hot line session at the European Society...

ESC 2021: Abbott’s Amulet occluder shows promise against Watchman device in AF treatment

Abbott has announced late-breaking data from the Amulet LAA Occluder IDE trial, a multicentre, h...

ESC 2021: Drones touted as the future of defibrillator delivery

The world’s first feasibility study has found that drones can be used to deliver defibrillators to p...

ESC 2021: New guidelines for the diagnosis and treatment of acute heart failure published

The European Society of Cardiology (ESC) Guidelines for the diagnosis and treatment of acute and chr...

ESC 2021: Study charts impact of following health advice after a heart attack

Adherence to lifestyle advice and medications could add seven healthy years of life after a heart at...

Second hospital implants Aeson bioprosthetic artificial heart

CARMAT has announced the second centre implanting its bioprosthetic artificial heart, Aeson, in the ...

Medtronic gains FDA approval for its latest-generation TAVI system

Medtronic has announced US Food and Drug Administration (FDA) approval of its newest-generation, sel...

ESC 2021: Family history outweighed by lifestyle choices in study of premature heart attacks

Young heart attack victims are more likely to be smokers, obese, and have high blood pressure or...

EMPOWER trial to study Carillon mitral contour system

Cardiac Dimensions has announced the launch of the US pivotal study the EMPOWER trial, evaluatin...

Urgent TAVI patients more likely to be readmitted than elective cases

Readmissions within 30 days are more common following urgent, rather than elective, transcathete...

Cardiovascular News 62 – August 2021: OUS Edition

In this issue: Meta analysis draws out debate on coronary revascularisation What to expect w...

Cardiovascular News 62 – August 2021: US Edition

In this issue: Meta analysis draws out debate on coronary revascularisation What to expect w...

Ten-year outcomes of Yukon DES in diabetic patients published in JAHA

Translumina has announced the publication of 10-year clinical outcome data for its Yukon drug-elutin...

Ultromics completes US$33 million Series B funding round

Ultromics, a developer of AI enabled cardiovascular imaging solutions, has announced that it has rai...

FDA grants breakthrough device designation to Impella ECP

The US Food and Drug Administration (FDA) has granted breakthrough device designation to Abiomed...

Algorithm predicts heart failure hospitalisations

AI
Biotronik has announced the results from a new study published in EP Europace this week confirming t...

Sinomed announces the first commercial implantation and European launch of the HT Supreme DES

Sinomed has announced the first commercial implantation of the HT Supreme drug-eluting stent (DE...

App launched to cut time to treatment for STEMI patients

Physicians at Mount Sinai Health System (New York, USA) have developed a mobile application to exped...

Second US FDA breakthrough device designation granted to CytoSorbents’ DrugSorb-ATR

CytoSorbents has been granted a second breakthrough device designation for its DrugSorb-ATR antithro...

Abbott’s Amplatzer Amulet gains US FDA approval

Abbott has announced that the US Food and Drug Administration (FDA)  has approved the company's ...

Occlutech gains IDE approval for OCCLUFLEX pivotal study

Occlutech Holding has announced the conditional US Food and Drug Administration (FDA) approval of it...

“Virtual contrast agent” could offer benefit in cardiac MRI assessment

An imaging technology developed using artificial intelligence (AI) could become an alternative for l...

Caption Health gains NTAP authorisation from CMS for AI-guided ultrasound platform

Caption Health has announced that the Centers for Medicare and Medicaid Services (CMS) have appr...

Women underrepresented in cardiovascular clinical trials

Women remain underrepresented in cardiovascular clinical trials despite initiatives to ensure broade...

Realview Imaging gains FDA approval for Holoscope-i system

RealView Imaging has announced that it has received US Food and Drug Administration (FDA) 510(k) cle...

Back in the room: A welcome return to in-person education

With the COVID-19 pandemic having switched virtually all of the major meeting in the cardiovascu...

Cardiovascular News’ top 10 most popular stories of July 2021

Our top 10 stories of July 2021, including: A milestone for coronary balloon angioplasty; highlights...

Analysis reports “dramatic” drop in cardiac surgery procedures during COVID-19

The largest analysis of its kind to look at the impact of COVID-19 on adult cardiac surgery volu...

US launch for Abbott’s Ultreon AI-based coronary imaging platform

Abbott has announced that it has received US Food and Drug Administration (FDA) clearance for its la...

Edwards’ Konect Resilia and Mitris Resilia gain Health Canada approval

Edwards Lifesciences has announced that it has received regulatory approval from Health Canada for b...

PCI procedures drop by 10% in USA since 2010, research suggests

The USA saw a 10% decline in percutaneous coronary intervention (PCI) procedures between 2010 an...

AngelMed launches its Guardian device in the USA

Angel Medical Systems (AngelMed) has announced the first commercial implantation and US launch of it...

TVT 2021: MitraClip reduces hospitalisation in patients with secondary MR and heart failure

An analysis of the rates rehospitalisation and mortality in heart failure patients with secondar...

Medtronic launches Prevail DCB in Europe

Medtronic has announced the launch of the Prevail drug coated balloon (DCB) catheter in Europe follo...

ADVERTORIAL: DCB pioneer welcomes deliverability after first case with Medtronic’s brand new Prevail™ coronary DCB

This advertorial is sponsored by Medtronic The first case using the Prevail (Medtronic) pacli...

CathWorks FFRangio system receives reimbursement approval in Japan

CathWorks has announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has appr...

TVT 2021: Aborted TEER leads to poorer outcomes in mitral valve surgery

Among patients undergoing mitral valve surgery after failed transcatheter edge-to-edge mitral va...

TVT 2021: 3M study suggests minimalist TAVI is safe, leads to “substantial” cost savings

Clinical and economic results from the 3M TAVR economic study have been presented at TVT 2021 (T...

TVT 2021: Outcomes in low-risk bicuspid and tricuspid TAVI patients similar at one year

Patients with bicuspid aortic stenosis may benefit as much from transcatheter aortic valve impla...

TVT 2021: Two-year PINNACLE FLX results report low rate of ischaemic stroke for Watchman FLX

Two-year results from the PINNACLE FLX clinical trial assessing the safety and efficacy of the next-...

MedAlliance launches Origin balloons for vessel preparation

MedAlliance has launched Origin SC and Origin NC, two high performance balloons for vessel preparati...

Ancora Heart secures US$80 million in financing

Ancora Heart has closed US$80 million in equity financing, with the funds to be used to accelera...

HeartFlow announces merger agreement

HeartFlow has entered into a definitive business combination agreement with Longview Acquisition...

First Aeson bioprosthetic artificial heart implanted in USA

Carmat has announced the first implantation of its bioprosthetic artificial heart, Aeson, in the USA...

Pacemaker implantation after SAVR points to increased mortality and heart failure hospitalisation

Patients undergoing permanent pacemaker implantation after surgical aortic valve replacement (SA...

First patients treated with reSept ASD occluder in IDE trial

atHeart Medical has announced the successful treatment of the first five patients in its ASCENT ...

FDA approval for SafeCross transseptal RF system

East End Medical has announced it has received US Food and Drug Administration (FDA) clearance f...

Cardiovascular societies demand action to combat physician burnout

Global action is needed to improve clinician wellbeing, according to four leading cardiovascular hea...

Xeltis initiates synthetic restorative pulmonary heart valve pivotal trial

Xeltis has announced that it has started a pivotal trial for a synthetic restorative pulmonary valve...

Common cath lab practices under the microscope in AHA review

The American Heart Association (AHA) has published a scientific statement challenging “tradition...

Cardiovascular News’ top 10 most popular stories of June 2021

Our top 10 stories of June 2021, including: Analysis of the data for transcatheter aortic valve impl...

CytoSorbents gains IDE for STAR-T trial to remove ticagrelor during cardiothoracic surgery

CytoSorbents has received approval for its investigational device exemption (IDE) application to con...

Carta Healthcare’s AI software certified for use in CathPCI Registry

virtual stroke care
Carta Healthcare has announced that it has been certified as a National Cardiovascular Data Registry...

Sinomed partners with NUI Galway for HT Supreme stent trial

Sinomed has announced a partnership with the National University of Ireland Galway (NUI Galway, ...

More experienced TAVI centres “less likely to use heart team approach”

Assessment of patients by both interventional cardiologists and cardiac surgeons prior to transc...

First patient treated with VeriSight Pro 3D intracardiac echocardiography catheter

Royal Philips has announced the first procedure using its real-time 3D intracardiac echocardiography...

Xience stent receives US FDA approval for short-duration DAPT

Abbott has today announced that its Xience family of stents has received US Food and Drug Admini...

Cardiothoracic surgery guidelines updated to optimise blood management among cardiac patients

Clinical practice guidance released today outline recommendations for reducing blood loss during...

Electroducer raises funding to market its external pacemaker device

Electroducer has announced that it has raised €3 million (US$3.65M) from private investors and Frenc...

Vaccine myocarditis risk “far outweighed” by COVID-19 infection

The risk of heart damage from COVID-19 infection is far greater than that from receiving a dose of t...

Pandemic contributes to worsening heart attack outcomes, study finds

Heart attacks during the COVID-19 pandemic were more likely to result in heart failure compared ...

AngelMed gains FDA approval for enhanced real-time cardiac monitor for ACS events

Angel Medical Systems (AngelMed) has announced US Food and Drug Administration (FDA) approval of the...

One in eight CABG patients readmitted within 30 days, meta-analysis finds

Nearly one in eight coronary artery bypass graft (CABG) patients are readmitted within 30 days o...

Medtronic Canada completes end-to-end remotely-guided TAVI procedure

The first end-to-end remotely guided transcatheter aortic valve implantation (TAVI) procedure us...

Tendyne receives breakthrough designation for MAC patients

Abbott has received Breakthrough Device designation from the US Food and Drug Administration (FD...

Royal Philips announces start of DEFINE GPS study

Philips iFR Coregistration SyncVision
Royal Philips has announced the official start of the DEFINE GPS study, with the first patient b...

Registry DAPT data “could support clinical trials”

Data captured in the National Cardiovascular Data Registry (NCDR) is similar in quality, depth a...

Long-term study finds QoL improvements in CABG patients despite complications

An investigation into the impact of postoperative complications on long-term quality of life (QoL) a...

Cindy Grines

Cindy Grines is an interventional cardiologist and chief scientific officer of Northside Hospital Ca...

PCI complexity does not influence efficacy of ticagrelor or prasugrel in acute coronary syndrome patients

In patients with acute coronary syndrome treated with percutaneous coronary intervention (PCI), ...

“Rapid increase” in cardiovascular disease-related deaths in Asia

The number of people dying from cardiovascular disease (CVD) in Asia is increasing rapidly, with ove...

Study of CorWave’s LVAD presented at ASAIO annual meeting

CorWave has announced that it has successfully completed the first 90-day preclinical study to evalu...

Circulation publishes special edition dedicated to disparities in cardiovascular medicine

Circulation the flagship journal of the American Heart Association (AHA) has published online its fi...

Shockwave’s coronary IVL device gains TPT payment approval

Shockwave Medical has announced today that the Centers for Medicare & Medicaid Services (CMS) ha...

Delaying CABG after AMI may not improve outcomes

A study looking at the timing of coronary artery bypass grafting (CABG) after the occurrence of acut...

Caution needed for TAVI in younger, low-risk aortic stenosis patients

Pivotal trials of transcatheter aortic valve implantation (TAVI) in low-risk patients have, so f...

Neurescue’s aortic occlusion device gains US FDA approval

Neurescue has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance ...

Pulmonary artery proportional pulse pressure monitoring could improve survival for heart failure patients

A new physiological measurement of heart function could improve survival for people with heart f...

TRISCEND study demonstrates significant reduction in TR with Evoque tricuspid valve

Early experience with the Evoque (Edwards Lifesciences) tricuspid valve replacement system demonstra...

GE Healthcare and ACC partner to advance AI in cardiology

GE Healthcare is collaborating with the American College of Cardiology (ACC) through support of and ...

Medtronic stops sale of its HVAD system

Medtronic is stopping the distribution and sale of the Medtronic HVAD system. This morning, the ...

Targeted healing: A new stent concept that could contribute to shortened DAPT

This advertorial is sponsored by Sinomed As newer-generation drug-eluting stent (DES) technol...

Cardiovascular News’ top 10 most popular stories of May 2021

Our top 10 stories of May 2021, including highlights from both EuroPCR 2021 (18–20 May, virtual), an...

Physician gender does not impact outcomes in PCI patients

There does not appear to be a relationship between operator and patient gender and outcome in patien...

Siemens Healthineers receives CE mark for the ACUSON AcuNav Volume ICE catheter

Siemens Healthineers has announced that it has received CE Mark for the AcuNav Volume ICE (intracard...

LivaNova completes initial divestiture of its heart valve business

LivaNova has successfully completed the initial closing of the divestiture of its heart valve bu...

Female aortic dissection patients presenting later, have higher mortality

Women who experience acute aortic dissection are older, have more advanced disease than men when...

Abiomed acquires breakthrough device company preCARDIA

Abiomed has acquired preCARDIA, developer of a proprietary catheter and controller to expand options...

Sinomed announces presentation of PIONEER III data at EuroPCR 2021

Sinomed has announced results from the HT Supreme healing-targeted drug-eluting stent (DES), in ...

Patients at high risk of bleeding—A forgotten population in PCI?

There is an increasing understanding of the need for tailored strategies when treating  high-bleedin...

COVID-19 puts a spotlight on the need for investment in resources for cardiac surgery

A call for greater investment in surgical facilities in the UK in the wake of the COVID-19 pandemic ...

EuroPCR 2021: Interventional cardiologists sound the alarm over silent impact of the pandemic

Interventional cardiologists from across the globe are joining forces for a campaign reinforcing...

Intravascular lithotripsy: Not an eccentric option for eccentric calcium

This advertorial is sponsored by Shockwave Medical. Severe coronary artery calcification presents...

MDR comes into effect across EU

The European Union (EU) Medical Devices Regulation (MDR) takes effect from today (26 May 2021). T...

First-in-human use of Tria biopolymer heart valve completed

Tria
Foldax has announced the successful first-in-human use of its biopolymer Tria heart valve in surgica...

First patients treated with Aortix pMCS device

complete-revascularisation
Procyrion has announced the treatment of the first patients in the pilot trial to evaluate the perfo...

EuroPCR 2021: Image-guided PCI study demonstrates non-inferiority of ultra-thin stent

Investigation of the use of an ultra-thin strut biopolymer sirolimus-eluting (BP-SES; Orsiro, Bi...

RE-ACCESS study has implications for TAVI valve selection

This advertorial is sponsored by Boston Scientific In recent years, transcatheter aortic valv...

TricValve transcatheter bicaval valve system receives CE mark

OrbusNeich and P&F Products & Features, under the joint partnership OrbusNeich P&F, have...

EuroPCR 2021: Study details dual mechanism of Diamondback orbital atherectomy system

Results of an observational study using optical coherence tomography (OCT) to assess the efficac...

EuroPCR 2021: FUTURE-II hints at promise for Firesorb bioresorbable scaffold

One-year results of the FUTURE-II study—a randomised trial comparing a thin-strut bioresorbable ...

EuroPCR 2021: Meta-analysis supports elective coronary revascularisation

A meta-analysis of randomised trials comparing a strategy of revascularisation plus medical therapy ...

ACC.21: Clopidogrel monotherapy trumps aspirin for long-term maintenance after PCI

Clopidogrel monotherapy produced better outcomes than aspirin for the long-term maintenance of p...

EuroPCR 2021: 10-year DISCOVER-FLOW results back HeartFlow FFRct analysis

HeartFlow has announced new data which indicate that the information provided by the HeartFlow F...

ACC.21: VOYAGER PAD analysis shows reduced risk of ischaemic events in PAD patients receiving rivaroxaban

Rivaroxaban (Xarelto, Bayer/Janssen), in addition to low-dose aspirin, should be considered as a...

EuroPCR 2021: Two-year results of Evolut Low Risk trial “reassuring” for TAVI in low-risk patients

Complete two-year follow-up data from the Evolut Low Risk trial, presented during a late-breakin...

EuroPCR 2021: Biotronik touts two-year data from BIOSOLVE-IV registry

Long-term follow-up data from the BIOSOLVE-IV registry, presented at the EuroPCR 2021 meeting (1...

FAST II underscores vFFR as a “faster and easier” physiological lesion assessment tool

This advertorial is sponsored by PIE Medical Findings of the multicentre FAST II clinical tri...

EuroPCR 2021: Registry data show low rates of PVL and PPI for Acurate neo2

Data presented at hotline and late-breaking trial sessions at the EuroPCR 2021 congress (18–20 M...

EuroPCR 2021: Philips shares cardiac imaging and software developments

Royal Philips has announced the European availability of new innovations in its portfolio of solutio...

ZOLL Medical receives FDA IDE approval for ISO Shock study

ZOLL Medical Corporation has announced that the US Food and Drug Administration (FDA) has approv...

Abbott’s Navitor TAVI system receives CE mark

Abbott has announced it has received CE mark for its latest-generation transcatheter aortic valve im...

ACC.21: High-sensitivity troponin T-test protocol did not improve outcomes in suspected ACS patients

Among patients with suspected acute coronary syndrome (ACS), the use of a high-sensitivity tropo...

ACC.21: Pandemic has seen burnout “double” among cardiology professionals

The proportion of cardiologists reporting burnout has nearly doubled during the COVID-19 pandemi...

ACC.21: FLOWER-MI finds no benefit to FFR-guided PCI in STEMI patients with multi-vessel disease

ST-elevation Myocardial Infarction (STEMI) patients with multi-vessel disease undergoing percuta...

ACC.21: DAPT de-escalation may benefit AMI patients

Switching from ticagrelor to clopidogrel dual antiplatelet therapy (DAPT) after 30 days was safe...

ACC.21: Registry data show low rate of stroke at one year following LAAO with Watchman

Transcatheter left atrial appendage occlusion (LAAO) with a Watchman (Boston Scientific) device ...

ACC.21: Apixaban not superior to standard of care following TAVI

Apixaban was not superior to standard of care following transcatheter aortic valve implantation ...

ACC.21: LAAO after heart surgery offers “new paradigm” for stroke prevention in AF patients

Patients with an elevated risk of stroke due to arrhythmia or atrial fibrillation (AF), were much le...

COBRA PzF stent demonstrates long-term safety at five years post-PCI

CeloNova BioSciences that its COBRA PzF nanocoated coronary stent (NCS) achieved exceptional lon...

Philips adds haemodynamic measurement to Azurion image-guided platform

Royal Philips has announced the integration of its Interventional Hemodynamic system and portable pa...

Leaflex: Changing the conversation around aortic stenosis?

This advertorial is sponsored by Pi-Cardia As more transcatheter aortic valve implantation (TAVI)...

Preventing kidney damage in the cath lab

This advertorial is sponsored by Osprey Medical There is a growing recognition of the risk of con...

Hostile environment: Cardiologists report high prevalence of discrimination and harassment in the workplace

Discrimination and harassment are a common experience among those working in cardiology, according t...

Cardiovascular News 61 – May 2021: OUS Edition

In this issue: Hostile environment: How cardiologists feel about discrimination in the workplac...

Cardiovascular News 61 – May 2021: US Edition

In this issue: Hostile environment: How cardiologists feel about discrimination in the wo...

Study shows increasing diversity among US cardiothoracic surgery residents

Research presented at the American Association for Thoracic Surgery 101st Annual Meeting (AATS 2021,...

ACC.21: Digital app should replace stent cards as a patient PCI record

Fewer than half (48%) of patients undergoing percutaneous coronary intervention (PCI) still had ...

Cardiology trainees require preparation to adapt to shift towards telemedicine

A significant proportion of cardiology trainees are uncomfortable with using telemedicine and fe...

AGENT IDE trial to evaluate DCB-use in patients with coronary in-stent restenosis

Boston Scientific has announced it has initiated the AGENT IDE trial for the Agent drug-coated ballo...

Mild COVID-19 unlikely to lead to lasting heart damage

Mild COVID-19 infection is unlikely to cause lasting damage to the structure or function of the hear...

Abbott initiates trial focusing on twin AF and heart failure treatments

Abbott has announced a new trial focused on improving the treatment for people simultaneously battli...

Cardiovascular News’ top 10 most popular stories of April 2021

Our top 10 stories of April 2021, including: highlights from the Society for Cardiovascular Angiogra...

ACC.21: App speeds up time to PCI for STEMI patients

ST-elevation myocardial infarction (STEMI) patients received percutaneous coronary intervention (PCI...

SCAI names Timothy Henry as president

Timothy D Henry (The Christ Hospital Medical, Cincinnati, USA) has assumed the office of preside...

Mitral regurgitation patients treated with TEER will require mitral replacement surgery if treatment fails

Patients suffering from severe mitral regurgitation should be carefully screened and counselled befo...

Medtronic’s Evolut PRO+ TAVI system gains CE mark

Medtronic has announced that it has received the CE mark for the Evolut PRO+ transcatheter aorti...

SCAI 2021: ISCHEMIA trial population not reflected in real-world patients

Patients studied in the ISCHEMIA trial, the largest trial to date to compare revascularisation w...

SCAI 2021: Robotic PCI achieves high clinical and technical success “in a wide spectrum of lesions”

Robotic-assisted percutaneous coronary intervention (PCI) using the second-generation CorPath GR...

SCAI 2021: Prolonged DAPT “should remain the standard of care” in ACS patients

Analysis of the prospective Fuwai PCI Registry using selection criteria from the TWILIGHT trial, has...

SCAI updates consensus guidelines on cath lab standards

The Society for Cardiovascular Angiography and Interventions (SCAI) has released an expert consensus...

SCAI 2021: Research lays bare the impact of the COVID-19 pandemic on STEMI care

Two research papers presented at the Society for Cardiovascular Angiography and Interventions vi...

SCAI 2021: Interim OPTIMIZE PRO results point to benefit for cusp overlap TAVI technique

Medtronic has announced results from an interim analysis of the first 171 patients (including 71...

Hospitalised COVID-19 patients at risk of developing heart failure

Patients hospitalised with COVID-19 may be at risk of developing heart failure even if they do n...

CE mark for BACE device for functional mitral regurgitation

Phoenix Cardiac Devices has announced that it has received CE mark for its Basal Annuloplasty of the...

CytoSorbents granted US FDA approval for STAR-T trial

CytoSorbents has announced that the US Food and Drug Administration (FDA) has granted conditional ap...

Societies publish initial findings of NACMI registry of STEMI patients with COVID-19

Initial findings from the North American Cardiovascular COVID-19 Myocardial Infarction (NACMI) R...

First patient enrolled in PROTECT IV randomised controlled trial of Impella

Abiomed has announced that the first patient has been enrolled in PROTECT IV, a large, prospecti...

Researchers create heart replicas from CT images

Researchers from King's College London (London, UK) have created 3D replicas of full-sized healthy a...

UK study suggests that COVID-19 patients are at elevated risk during cardiothoracic surgery

A retrospective observational study of patients undergoing cardiac surgery in the UK between March a...

Cardiothoracic surgeons mobilised for COVID-19 research

The work of the Cardiothoracic Surgical Trials Network (CTSN) in mobilising resources for COVID-19 r...

AcQCross transseptal crossing devices gain US FDA clearance

Acutus Medical has announced US Food and Drug Administration (FDA) clearance of the AcQCross family ...

First procedure performed in SMART head-to-head TAVI study

The first procedure has been completed in SMART (Small Annuli Randomized to Evolut or Sapien) po...

Next generation TriClip gains CE mark approval

Abbott has received CE mark for its next-generation TriClip transcatheter tricuspid valve repair sys...

Cardiovascular News’ top 10 most popular stories of March 2021

Our top 10 stories of March 2021, including: highlights from CRT 2021; converging TAVI and surgery o...

COVID-19 “lays the foundation for a digital shift in cardiovascular care”

More patients, particularly those with medical risk factors or from underserved communities, opt...

Understanding trends in TAVI and surgical aortic valve replacement

With recent data pointing to a shift towards more transcatheter aortic valve implantation (TAVI) pro...

Xience stent receives CE mark for short duration DAPT

Abbott has announced that its Xience stent has received CE mark in Europe for shorter duration o...

Dipti Itchhaporia begins term as ACC president

Dipti Itchhaporia has today begun her term as president of the American College of Cardiology (A...

Randomised trial data supports use of the PleuraFlow system

ClearFlow has announced clinical trial results published in the Journal of Cardiothoracic Surgery ev...

One in three female cardiologists report unwanted advances

More than a third of female cardiologists polled in a UK survey on discrimination and sexism in the ...

Older STEMI patients found to be more reluctant to undergo PCI in Chinese study

Patients aged over 65 years were more likely than their younger counterparts to turn down percutaneo...

How the LightLab initiative is examining the value of OCT in the cath lab

Matheen Khuddus (director of Cardiovascular Research, The Cardiac & Vascular Institute, Gainesvi...

B Braun and Infraredx collaborate on IDE clinical trial for the SeQuent Please ReX

B Braun Interventional Systems has announced a collaboration with Infraredx to accelerate the US Foo...

Alvimedica gains CE mark approval for Fluydo NC balloon catheter

Alvimedica has announced CE mark approval of Fluydo NC, its PTCA non-compliant balloon catheter. ...

Medtronic receives FDA approval for Harmony transcatheter pulmonary valve

Medtronic has received US Food and Drug Administration (FDA) approval for its Harmony transcatheter ...

Academic reputation does not determine following for interventional cardiology influencers

Social media has become an important platform for promoting research within the interventional cardi...

Cordella pulmonary artery pressure sensor reaches 100-implant milestone

Endotronix has announced the 100th global implant of the Cordella pulmonary artery pressure sens...

Viagra may prolong life for men with coronary artery disease

Men with stable coronary artery disease who receive Viagra due to impotence seem to live longer ...

Shockwave Medical to bring IVL to the Chinese market

Shockwave Medical has announced that the company has signed an agreement to form a joint venture wit...

Mavacamten granted US FDA new drug application

Bristol Myers Squibb has announced that the US Food and Drug Administration (FDA) has accepted its n...

Stephan Achenbach

Stephan Achenbach is professor of medicine at the University of Erlangen, Erlangen, Germany and pres...

CRT 2021: Three-year COMPARE ABSORB results show similar TLF rate between Absorb scaffold and Xience stent

Three-year results from the COMPARE-ABSORB trial, presented during a late-breaking trial session...

CRT 2021: Polymer-free amphilimus-eluting stent non-inferior to zotarolimus-eluting stent in PCI patients

Three-year clinical outcomes from the Recre8 trial, a multicentre study comparing the safety and eff...

Lab-grown heart valves capable of growth in recipient, research finds

Lab-created heart valves implanted in young lambs were capable of growth within the recipient, a...

Imbio receives FDA 510(k) clearance for cardiothoracic imaging algorithm

Imbio has received US Food and Drug Administration (FDA) 510(k) clearance for its RV/LV Analysis alg...

Cardiovascular Systems announces first uses of Wirion embolic protection system

Cardiovascular Systems has announced that the first patients in the USA have been treated with the W...

CytoSorbents files IDE for US trial on ticagrelor removal during cardiothoracic surgery

CytoSorbents has announced the filing of an investigational device exemption (IDE) application to co...

Elixir Medical commences INFINITY-SWEDEHEART randomised study of DynamX bioadaptor

Elixir Medical has today announced commencement of the INFINITY-SWEDEHEART randomised controlled tri...

CardioRisk: Addressing atherosclerotic risk factors among Egypt’s ACS patients

Ahmed Bendary (Benha University, Benha, Egypt) details the CardioRisk project, an initiative to ...

CRT 2021: BIOSTEMI shows superiority of Orsiro stent to Xience for target lesion failure at two years

Two-year follow-up data the BIOSTEMI trial, presented during a late-breaking trial session at th...

CRT 2021: One-year outcomes after TAVI in low-risk bicuspid aortic stenosis patients meet expectations

Clinical outcomes up to one year after transcatheter aortic valve implantation (TAVI) in low-ris...

Five-year results of Gore REDUCE clinical study published

Five-year follow-up results from the Gore REDUCE study, assessing the Gore Cardioform or Helex s...

ACC.21 late-breaking clinical trial programme announced

The American College of Cardiology (ACC) has announced a number of the late-breaking clinical trials...

CRT 2021: Registry data highlights growing use of DOACs among bioprosthetic heart valve patients

Registry data charting the use of direct oral anticoagulants (DOACs) in patients receiving mecha...

CRT 2021: Registry data finds BASILICA has a low coronary artery obstruction rate

Data from an international registry of patients undergoing a procedure known as BASILICA, which ...

Cardiovascular News’ top 10 most popular stories of February 2021

Our top 10 stories of February 2021, including: the relationship between TAVI volumes and outcomes; ...

Approval allows use of single access Impella procedure across Europe

Following consultation with its notified body, MEDCERT GmbH, Abiomed is introducing the single acces...

ControlRad Select imaging system gains FDA market clearance

ControlRad has announced US Food and Drug Administration (FDA) 510(k) clearance to market Contro...

Three-month DAPT after PCI with Synergy stent supported in EVOLVE Short DAPT trial

Favourable rates of ischaemic outcomes were observed among selected high bleeding risk patients ...

Societies collaborate to develop universal heart failure definition

A global collaboration between international heart failure bodies seeks to standardise the language ...

MedAlliance gains FDA breakthrough designation for sirolimus DEB treatment of de novo coronary lesions

MedAlliance has been awarded breakthrough status for Selution SLR, its sustained limus release drug-...

ICS announces first use of its Emblok system in Europe

Innovative Cardiovascular Solutions (ICS) has announced the success of its first European clinic...

FDA approval for Viola clampless proximal anastomosis device

Vascular Grafts Solutions has announced receipt of marketing clearance from the US Food and Drug Adm...

Two-year PARTNER 3 outcomes show convergence between TAVI and surgery on stroke and death

Two-year outcomes of the PARTNER 3 clinical trial, in which low surgical risk aortic stenosis pa...

CRT 2021: Analysis compares cangrelor favourably to glycoprotein IIB

An analysis of antiplatelet therapies used during percutaneous coronary intervention (PCI) has c...

Analysis shows proportionality fails to account for divergent COAPT and Mitra-FR trials

A secondary analysis of the COAPT trial, which sought to account for differences in the findings...

Data support use of AI to accurately estimate lesion-specific ischemia

Elucid, a developer of AI software to enable cardiovascular disease detection, has announced the pub...

Inovise gains breakthrough designation for non-invasive heart failure management system

Inovise Medical has announced that the US Food and Drug Administration (FDA) has granted breakth...

Occlutech announces completion of enrolment in study of atrial flow regulator in heart failure patients

Occlutech has announced the completion of patient enrolment in its pilot study to assess safety and ...

CRT 2021: DISRUPT CAD III sub-study shows efficacy of IVL in patients with longer lesions

A sub-analysis of the DISRUPT CAD III clinical trial, investigating use of Shockwave intravascul...

IVL is a safe and predictable tool against coronary calcium

After Shockwave Medical announced that its intravascular lithotripsy (IVL) technology received pre-m...

Terumo reaches agreement to acquire predictive analytics specialist Health Outcomes Sciences

Terumo Corporation has signed a definitive agreement to acquire all assets of Health Outcomes Scienc...

ACC.21 switches to a virtual-only meeting

The American College of Cardiology (ACC) has announced that its 70th annual scientific session, will...

Urgent action needed to address growing burden of heart failure

Urgent action is needed to address the growing burden of heart failure and the impact of COVID-1...

CRT 2021: Recre8 sub-analysis points to higher rate of clinically relevant bleeding in HBR patients during DAPT

A sub-analysis of the Recre8 trial, assessing patients at high bleeding risk (HBR) undergoing pe...

Study shows AI can “extend the reach” of echocardiographic assessment

Caption Health has announced the publication of a study in JAMA Cardiology assessing its artific...

OpSens gains CE mark for OptoWire III

OpSens has received CE mark approval for the OptoWire III, the latest generation of its flagship pro...

MRI study of COVID-19 patients with raised troponin levels reveals high rate of heart damage

Around 50% of patients who have been hospitalised with severe COVID-19 and have raised levels of...

What role will remote robotic procedures play in the future of PCI?

With the COVID-19 pandemic creating new barriers to the accessibility of healthcare, the success...

Teleflex completes enrolment in CTO-PCI IDE study

Teleflex has announced the completion of patient enrolment in a clinical study evaluating the perfor...

Shockwave IVL receives US FDA pre-market approval for severely calcified coronary artery disease

Shockwave Medical has announced that its intravascular lithotripsy (IVL) technology has received pre...

Ticagrelor monotherapy associated with a lower bleeding risk than standard DAPT after PCI

Dropping aspirin shortly after percutaneous coronary intervention (PCI) is associated with lower...

Substantial reduction in tricuspid regurgitation reported in 30-day outcomes of CLASP TR study of Pascal device

A study detailing early experience of the Pascal transcatheter valve system (Edwards Lifescience...

Off-pump CABG “an effective option” for patients with reduced ejection fraction

Off-pump coronary artery bypass grafting (OPCABG) is a safe and effective option for the treatment o...

Global heart failure cases soar since 1990

The number of patients with heart failure worldwide nearly doubled from 33.5 million in 1990 to 64.3...

Robotic treatment starts with the heart

Robotic-assisted treatment is on the cusp of achieving its full potential, says J Aaron Grantham, co...

New recommendations issued on antithrombotic treatment of AF patients undergoing PCI

Updated recommendations on the optimal antithrombotic treatment of patients with atrial fibrillation...

Meta-analysis points to “inverse” relationship between TAVI centre volume and outcomes

The authors of a systematic review and meta-analysis, looking at the effect of institutional tra...